Auxly Cannabis Group Inc. (TSXV:XLY) (OTCQX:CBWTF) has announced the receipt of key cannabis oil sales licenses, but Auxly stock has dropped nearly 4%.
The licenses apply to two of Auxly’s wholly-owned subsidiaries, Dosecann and Kolab, and will allow the company to sell cannabis oil products when they become legal following legalization 2.0 in October. While the company views this Health Canada approval as a significant milestone in furthering its brand strategy, investors in Auxly stock clearly aren’t feeling as bullish with shares dropping nearly 4% to $0.725.
Dosecann is Auxly’s home for derivative product ...
Read The Full Article On PotStockNews.com
Get the latest marijuana stock news, cannabis on stock news on PotStockNews
All content provided by Pot Stock News is subject to our Terms Of Use and Disclaimer.